Beat C Bornhauser (Beat Bornhauser)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Science advances

Blood

Advanced healthcare materials

Leukemia

University Children's Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University Children's Hospital May 01 2005

Switzerland

PHD :: Oncology

Publications

Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Furkan Gökçe, Alicia Kaestli, Christian Lohasz, Martina de Geus, Hans-Michael Kaltenbach, Kasper Renggli, Beat C Bornhauser, Andreas Hierlemann, Mario M Modena
Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Advanced healthcare materials 12 (6) (2023)
Furkan Gökçe, Alicia Kaestli, Christian Lohasz, Martina de Geus, Hans-Michael Kaltenbach, Kasper Renggli, Beat C Bornhauser, Andreas Hierlemann, Mario M Modena
Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Advanced healthcare materials (2023)
Furkan Gökçe, Alicia Kaestli, Christian Lohasz, Martina de Geus, Hans-Michael Kaltenbach, Kasper Renggli, Beat C Bornhauser, Andreas Hierlemann, Mario M Modena
Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Advanced healthcare materials 12 (6) (2023)
Furkan Gökçe, Alicia Kaestli, Christian Lohasz, Martina de Geus, Hans-Michael Kaltenbach, Kasper Renggli, Beat C Bornhauser, Andreas Hierlemann, Mario M Modena
Microphysiological Drug-testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Advanced healthcare materials (2023)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Paulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, Büşra Erarslan-Uysal, Beat C Bornhauser, Viktoras Frismantas, Yassen Assenov, Martin Zimmermann, Margit Happich, Caroline von Knebel-Doeberitz, Nils von Neuhoff, Rolf Köhler, Martin Stanulla, Martin Schrappe, Gunnar Cario, Gabriele Escherich, Renate Kirschner-Schwabe, Cornelia Eckert, Smadar Avigad, Stefan M Pfister, Martina U Muckenthaler, Jean-Pierre Bourquin, Jan O Korbel, Andreas E Kulozik
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution. Leukemia 36 (7) (2022)
Svenja Michalek, Thomas Goj, Anna Pia Plazzo, Blerim Marovca, Beat C Bornhauser, Thomas Brunner
LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance. EMBO reports 23 (9) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Qi Jin, Blanca T Gutierrez-Diaz, Tim Pieters, Yalu Zhou, Sonali Narang, Igor Fijalkwoski, Cristina Borin, Jolien Van Laere, Monique Payton, Byoung-Kyu Cho, Cuijuan Han, Limin Sun, Valentina Serafin, George Yacu, Wouter Van Loocke, Giuseppe Basso, Giulia Veltri, Ingrid Dreveny, Issam Ben-Sahra, Young Ah Goo, Stephanie L Safgren, Yi-Chien Tsai, Beat C Bornhauser, Praveen Kumar Suraneni, Alexandre Gaspar-Maia, Irawati Kandela, Pieter Van Vlierberghe, John D Crispino, Aristotelis Tsirigos, Panagiotis Ntziachristos
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science advances 8 (49) (2022)
Hyobin Jeong, Karen Grimes, Kerstin K Rauwolf, Peter-Martin Bruch, Tobias Rausch, Patrick Hasenfeld, Eva Benito, Tobias Roider, Radhakrishnan Sabarinathan, David Porubsky, Sophie A Herbst, Büşra Erarslan-Uysal, Johann-Christoph Jann, Tobias Marschall, Daniel Nowak, Jean-Pierre Bourquin, Andreas E Kulozik, Sascha Dietrich, Beat C Bornhauser, Ashley D Sanders, Jan O Korbel
Functional analysis of structural variants in single cells using Strand-seq. Nature biotechnology (2022)
Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordoʹ, Donna O Debets, Willem K Smits, Zhongli Chen, Jelle Dylus, Guido J R Zaman, Maarten Altelaar, Koichi Oshima, Beat C Bornhauser, Jean-Pierre Bourquin, Jan Cools, Adolfo A Ferrando, H Josef Vormoor, Rob Pieters, Britta Vormoor, Jules P P Meijerink
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia 35 (12) (2021)
Lenka Besse, Andrej Besse, Marianne Kraus, Elmer Maurits, Herman S Overkleeft, Beat C Bornhauser, Jean-Pierre Bourquin, Christoph Driessen
High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors. Cells 10 (11) (2021)
Caterina Mezzatesta, Liridon Abduli, Anna Guinot, Cornelia Eckert, Denis Martin Schewe, Marketa Zaliova, Luciana Vinti, Blerim Marovca, Yi-Chien Tsai, Silvia Jenni, Julia Aguade-Gorgorio, Arend von Stackelberg, Martin Schrappe, Franco Locatelli, Martin Stanulla, Gunnar Cario, Jean-Pierre Bourquin, Beat C Bornhauser
Repurposing anthelmintic agents to eradicate resistant leukemia. Blood cancer journal 10 (6) (2020)
Scott McComb, Pik Ki Chan, Anna Guinot, Holmfridur Hartmannsdottir, Silvia Jenni, Maria Pamela Dobay, Jean-Pierre Bourquin, Beat C Bornhauser
Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7. Science advances 5 (7) (2019)
Mohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, Christina Claus, Jean-Pierre Bourquin, Beat C Bornhauser, Ramin Radpour, Carsten Riether, Adrian Franz Ochsenbein
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood 130 (3) (2017)

Beat C Bornhauser.css-eqlu8i{font-size:small;padding-left:4px;} (Beat Bornhauser)

Publication Activity (10 Years)

Top Topics

Top Venues

Beat C Bornhauser (Beat Bornhauser)